Zhu Huadong, Bruck-Haimson Reut, Zaretsky Adam, Cohen Irit, Falk Roni, Achache Hanna, Tzur Yonatan B, Cohen Ehud
Department of Biochemistry and Molecular Biology, the Institute for Medical Research Israel-Canada, the Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Department of Genetics, The Alexander Silberman Institute of Life Sciences, Edmond J. Safra Campus, The Hebrew University of Jerusalem, Jerusalem, Israel.
Nat Cell Biol. 2025 Jan;27(1):87-102. doi: 10.1038/s41556-024-01564-y. Epub 2025 Jan 3.
The protein homeostasis (proteostasis) network encompasses a myriad of mechanisms that maintain the integrity of the proteome by controlling various biological functions, including protein folding and degradation. Alas, ageing-associated decline in the efficiency of this network enables protein aggregation and consequently the development of late-onset neurodegenerative disorders, such as Alzheimer's disease. Accordingly, the maintenance of proteostasis through late stages of life bears the promise to delay the emergence of these devastating diseases. Yet the identification of proteostasis regulators is needed to assess the feasibility of this approach. Here we report that knocking down the activity of the nucleolar FIB-1-NOL-56 complex protects model nematodes from proteotoxicity of the Alzheimer's disease-causing amyloid-β peptide and of abnormally long poly-glutamine stretches. This mechanism promotes proteostasis across tissues by modulating the activity of TGFβ signalling and by enhancing proteasome activity. Our findings point at research avenues towards the development of proteostasis-promoting therapies for neurodegenerative maladies.
蛋白质稳态(proteostasis)网络包含无数机制,这些机制通过控制各种生物学功能(包括蛋白质折叠和降解)来维持蛋白质组的完整性。遗憾的是,与衰老相关的该网络效率下降会导致蛋白质聚集,进而引发迟发性神经退行性疾病,如阿尔茨海默病。因此,在生命后期维持蛋白质稳态有望延缓这些毁灭性疾病的出现。然而,需要鉴定蛋白质稳态调节剂来评估这种方法的可行性。在此,我们报告敲低核仁FIB-1-NOL-56复合物的活性可保护模型线虫免受阿尔茨海默病致病淀粉样β肽和异常长的多聚谷氨酰胺链的蛋白毒性。这种机制通过调节TGFβ信号传导活性和增强蛋白酶体活性来促进全身组织的蛋白质稳态。我们的研究结果指出了开发促进蛋白质稳态的神经退行性疾病治疗方法的研究途径。